As millions of people around the globe clock in for shifts that extend into the late hours and overnight, a large-scale study has revealed a concerning and previously underappreciated occupational hazard connected to their work schedules. This comprehensive investigation provides significant new
Today we are speaking with Ivan Kairatov, a biopharma expert whose work at the intersection of public health and cancer epidemiology sheds light on one of the world’s most preventable cancers. We’ll be exploring the complex story behind cervical cancer: a disease for which we have the tools to
The ability to track cancer's genetic secrets through a simple blood draw is no longer a futuristic concept but a clinical reality facing its own set of critical challenges. For years, the field of oncology has been steadily moving away from invasive tissue biopsies toward liquid biopsies, a
Biopharma expert Ivan Kairatov joins us to discuss a groundbreaking advance in immunotherapy. While treatments like CAR-T cell therapy have shown incredible promise, they are not a solution for every patient, often because the necessary immune cells are rare or difficult to work with. Now,
A formidable new strategy has emerged in the fight against a particularly stubborn form of lung cancer, offering a beacon of hope for patients whose tumors have developed resistance to frontline treatments. Researchers from the Medical University of Vienna have pioneered a novel combination therapy
A conservative West Virginia lawmaker and a progressive California governor rarely find common ground, yet they have become improbable allies in a sweeping national movement to fundamentally reshape what Americans eat and how public health is managed. This decentralized but powerful crusade,
